Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans. Hims & ...

Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is still a buy.

“[We] will continue to provide compounded GLP-1RAs, even after the FDA has resolved the semaglutide shortage. Mochi can maintain these under personalised treatment plans because the medication ...

Hello Cake, is proud to use Epiq Scripts as its digital pharmacy providing personalized medication to its clients. About Epiq Scripts Epiq Scripts is a nationwide digital mail-order compounding ...

Eli Lilly, the maker of the diabetes drug Mounjaro and weight ... There have been reports of dosing errors associated with compounded semaglutide products, and some medical societies urge caution.

While there is not currently a shortage of Ozempic, previous difficulties in supplying this medication have led to some pharmacies offering compounded semaglutide. The Food and Drug Administration ...

"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications ... A more ...